Broser® (bromelain, escin and selenium), oral nutraceutical, monotherapy in patients with inflammatory otorhinolaryngological disorders.

Cupido, G F; Gelardi, M; La Mantia, I; Aragona, S E; Ciprandi, G

Cupido, G F; Gelardi, M; La Mantia, I; Aragona, S E; Ciprandi, G.

Affiliation

Cupido GF; ENT Department, University of Palermo, Palermo, Italy
Gelardi M; Otolaryngology Unit, Department of Basic Medical Science, Neuroscience and Sensory Organs, University of Bari Aldo Moro, Bari, Italy
La Mantia I; ENT Department, University of Catania, Catania, Italy
Aragona SE; Center of Regenerative Medicine, Humanitas Mater Domini, Castellanza (VA), Italy
Ciprandi G; Allergy Clinic, Casa di Cura Villa Montallegro, Genoa, Italy

J Biol Regul Homeost Agents ; 33(2): 609-615, 2019.

Article in En | MEDLINE | ID: mdl-30891997

Subject(s)

Bromelains/therapeutic use; Escin/therapeutic use; Inflammation/drug therapy; Otorhinolaryngologic Diseases/drug therapy; Selenium/therapeutic use; Anti-Inflammatory Agents/therapeutic use; Dietary Supplements; Humans

Key words

selenium; inflammation; otorhinolaryngology; bromelain; escin

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Otorhinolaryngologic Diseases / Selenium / Bromelains / Escin / Inflammation Type of study: Clinical_trials Limits: Humans Language: En Journal: J Biol Regul Homeost Agents Journal subject: BIOLOGIA / BIOQUIMICA Year: 2019 Type: Article Affiliation country: Italy

Search on Google

XML

PubMed Links